Latest clinical practice guidelines for seasonal influenza
Influenza is a common viral infection that occurs largely in the winter months. The Infectious Diseases Society of America recently released updated clinical practice guidelines for the management of seasonal influenza. Recommended antivirals for uncomplicated influenza in otherwise healthy patients in the outpatient setting include oral oseltamivir, inhaled zanamivir, and IV peramivir. Oseltamivir is preferred for hospitalized patients. Following publication of the guidelines, baloxavir marboxil was approved for outpatient treatment of uncomplicated influenza in persons aged 12 years and older. For prevention of influenza, recommended antivirals include oseltamivir and zanamivir. Pharmacists are in a key position to ensure that patients receive an annual influenza vaccine and to recommend appropriate antiviral therapy for the treatment and prophylaxis of influenza.
Sucher, Allana; Do, Andrea; and Negash, Mussie, "Latest clinical practice guidelines for seasonal influenza" (2019). Regis University Faculty Publications (comprehensive list). 269.